1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow TEV-50717: new trials by email Literature Review of TEV-50717 trials Research Report on TEV-50717
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents TEV-50717, Placebo - Tourette Syndrome | Phase 2 / Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 119 | 2018-02-05 | 2021-11-09 |
Teva Branded Pharmaceutical Products R&D, Inc. (1)
Canada (1) · Denmark (1) · Russia (1) · Serbia (1) · Spain (1) · United States (1)
2016 (1)